2-3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline and decamethrin

2-3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline has been researched along with decamethrin* in 1 studies

Other Studies

1 other study(ies) available for 2-3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline and decamethrin

ArticleYear
Prolonged expression of c-Fos and c-Jun in the cerebral cortex of rats after deltamethrin treatment.
    Brain research. Molecular brain research, 2003, Jan-31, Volume: 110, Issue:1

    In this study we investigated the effects of deltamethrin on the expression of c-Fos and c-Jun in the cerebral cortex of rats. Immunohistochemical analysis demonstrated that the immunoreactivity for c-Fos was markedly increased in the cerebral cortex 5 h after deltamethrin treatment, and maintained at an increased level at 24 h, even though little immunoreactivity for c-Fos was seen in the same brain region of control rats. The immunostaining for c-Jun was also dramatically elevated in the same brain region, showing the same time course of c-Fos expression after deltamethrin treatment. Further, both MK-801, an N-methyl-D-aspartate (NMDA) receptor antagonist, and NBQX, an alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA)/kainate (KA) receptor antagonist, attenuated deltamethrin-elicited prolonged expression of c-Fos and c-Jun. Since the persistent expression of c-Fos and c-Jun is unusual, and has been reported before in conditions involving neurodegeneration, our results are consistent with a model that deltamethrin induces neurodegeneration through a glutamate-dependent pathway.

    Topics: Animals; Cerebral Cortex; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Immunohistochemistry; Insecticides; Male; Nitriles; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Pyrethrins; Quinoxalines; Rats; Rats, Sprague-Dawley

2003